The Protein Man's Blog | A Discussion of Protein Research

Protein instability rarely announces itself with obvious warning signs. A sample that appears homogeneous after purification may show visible aggregation overnight; an enzymatic assay that previously yielded reproducible results may yield inconsistent kinetics; aliquots subjected to repeated freeze-thaw cycles may exhibit progressive loss of biological activity. In such cases, the buffer system formulation is the underlying cause — yet it remains among the last variables scrutinized during troubleshooting.

Buffer formulation should be addressed as a primary experimental variable once core experimental parameters are established. Approaching it systematically and deliberately has measurable consequences for protein behavior across purification workflows, storage conditions, and downstream functional applications.

Histology is the microscopic study of tissues and organs through sectioning, staining, and examination. Histology allows for the visualization of tissue structure and characterization of changes the tissue may have undergone. It is utilized in medical diagnosis, scientific study, autopsy, and forensic investigation.

Life scientists know the frustration of running PCR (Polymerase Chain Reaction), checking the product on a gel or sequencing, and discovering that the amplified product contains unwanted DNA sequence. A single base error or insertion can alter a reading frame, disrupt a protein’s function, and compromise downstream analysis and application. These issues can originate during amplification if the choice of DNA polymerase fails to provide the accuracy the application requires. Selecting the right DNA polymerase enzyme is critical for achieving accurate, reproducible amplification, especially when the application demands high fidelity.